Associate Director, Regulatory Affairs - Biosimilars (US)

Sandoz•Princeton, NJ

9d•$145,600 - $279,400•Hybrid

About The Position

The Associate Director, Regulatory Affairs – Biosimilars (US) is responsible for leading US regulatory strategy and execution for biosimilar development programs and marketed products. This role serves as the US regulatory lead for assigned biosimilar assets, providing strategic direction, leadership in FDA interactions, and hands on oversight of regulatory submissions. The position partners cross functionally to enable timely approvals and maximize lifecycle value while ensuring compliance with US regulatory requirements. Sandoz continues to go through an exciting and transformative period as a global leader and pioneering provider of sustainable Biosimilar and Generic medicines. As we continue down this new and ambitious path, unique opportunities will present themselves, both professionally and personally. Join us, the future is ours to shape!

Requirements

Bachelor’s degree in Life Sciences (Biology, Pharmacy, Chemistry, Biotechnology, or related field) required
Minimum of 7 years of regulatory affairs experience within the biopharmaceutical industry, including hands-on experience with US biosimilar programs and BLA (351(k)) submissions.
Strong working knowledge of FDA regulations, guidance, and processes applicable to biosimilar development and post-marketing activities.
Demonstrated experience preparing regulatory submissions and leading FDA interactions.
Ability to work independently while effectively influencing and collaborating within cross-functional, matrixed teams.
Excellent written and verbal communication skills with strong attention to detail.

Nice To Haves

Advanced degree (MS, PhD, PharmD) preferred
Strong organizational skills with the ability to manage multiple priorities effectively.
Experience in a global regulatory environment and collaboration with ex-US regulatory teams

Responsibilities

Develop and lead US regulatory strategies for biosimilar programs from early development through post‑approval lifecycle management.
Serve as the regulatory subject matter expert on US biosimilar regulations, guidance, and evolving FDA expectations.
Oversee the preparation, review, and submission of INDs, BLAs (351(k)), amendments, supplements, information request responses, post‑approval commitments, and annual reports.
Lead and support FDA interactions, including Pre‑IND, Biosimilar Product Development (BPD), and other regulatory and scientific advice meetings.
Provide regulatory leadership and guidance in partnership with Clinical, Nonclinical, CMC, Analytical Development, Quality, Pharmacovigilance, Medical Affairs, Legal, and Commercial teams.
Manage post‑approval US regulatory activities, including labeling updates, safety‑related submissions, manufacturing and comparability changes, and inspection readiness support.
Partner with global development and technical operations teams to ensure high‑quality BLAs, amendments, and supplements that meet FDA requirements.
Ensure ongoing regulatory compliance with US pre‑ and post‑approval filing, reporting, and regulatory obligations.
Represent US Regulatory Affairs at internal (US and global) governance forums and external meetings with regulatory authorities and partners.